Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

579
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
579
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.1K
The pathophysiology of pneumonia involves the following steps:
2.1K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

355
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
355
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

2.7K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.7K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

573
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
573
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.0K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same author

Immunological insights into why pertussis continues to be endemic.

Human vaccines & immunotherapeutics·2026
Same author

Diagnostic performance and interchangeability of two commercial anti-RSV-IgG and IgA ELISAs across clinically relevant populations.

Microbiology spectrum·2026
Same author

Vaccination Against Serogroup B Meningococcal Disease: Current Status and Future Perspectives-A Consensus Document of the World Association for Infectious Diseases and Immunological Disorders (WAidid).

Vaccines·2026
Same author

Genome-wide association study of paediatric bacteraemia and sepsis.

EBioMedicine·2026
Same author

Review on pertussis case definitions: a need for reliable disease surveillance.

BMC infectious diseases·2026
Same journal

[Outpatient pulmonary rehabilitation].

Der Pneumologe·2022
Same journal

[Parapneumonic pleural effusion in a 37-year-old female patient?]

Der Pneumologe·2022
Same journal

[Development and progress].

Der Pneumologe·2022
Same journal

[Development and progress in mechanical ventilation].

Der Pneumologe·2022
Same journal

[Development and progress in respiratory tract infections].

Der Pneumologe·2022
Same journal

[Benefits and risks of treatment with oxygen].

Der Pneumologe·2022
See all related articles

Related Experiment Video

Updated: Dec 6, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.0K

[Pertussis (whooping cough)].

Ulrich Heininger1,2

  • 1Universitäts-Kinderspital beider Basel, Spitalstr. 33, 4056 Basel, Schweiz.

Der Pneumologe
|October 12, 2020
PubMed
Summary
This summary is machine-generated.

Pertussis, caused by Bordetella pertussis, is a serious respiratory illness, particularly in infants. Vaccination, especially in pregnant women, is key to preventing severe cases and hospitalizations.

Keywords:
AntibioticsBordetella pertussisImmunizationPolymerase chain reactionTransmission

More Related Videos

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.4K
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

48.7K

Related Experiment Videos

Last Updated: Dec 6, 2025

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

11.0K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.4K
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
13:27

Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia

Published on: May 6, 2014

48.7K

Area of Science:

  • Bacteriology
  • Infectious Diseases
  • Pediatrics

Context:

  • Pertussis (whooping cough) is a highly contagious respiratory infection caused by the Gram-negative bacterium Bordetella pertussis.
  • Disease severity ranges from mild cough to life-threatening complications like hyperleukocytosis and respiratory failure, especially in infants.
  • Diagnosis relies on clinical presentation and microbiological detection.

Purpose:

  • To provide a comprehensive overview of pertussis, including its causative agent, clinical spectrum, diagnosis, treatment, epidemiology, and prevention strategies.
  • To highlight the critical role of vaccination in controlling pertussis, particularly in vulnerable populations.
  • To emphasize the effectiveness of maternal vaccination and timely infant immunization.

Summary:

  • Pertussis is caused by Bordetella pertussis, presenting with varied symptoms and posing significant risks to infants, often requiring hospitalization.
  • Treatment involves macrolide antibiotics, with caffeine used for apnea. Incidence rates are highest in infants and adolescents.
  • Prevention strategies include routine immunization with acellular vaccines and booster doses.
  • Maternal vaccination during pregnancy is the most effective method to protect young infants from severe pertussis.
  • Infants require timely immunization starting at two months of age for their own protection.

Impact:

  • Vaccination, particularly maternal immunization, significantly reduces severe pertussis cases and hospitalizations in infants.
  • Understanding pertussis epidemiology and transmission is crucial for public health interventions and vaccine program optimization.
  • Effective control of pertussis relies on maintaining high vaccination coverage across all age groups.